Financing DiaGenic ASA

With reference to the statement in presentation of the 3rd Quarter report 2009 that the Board is working to secure further financing of the Company, DiaGenic and its advisors has now decided to carry out an equity offering through a private placement. The book building will start after the close of Oslo Stock Exchange today.

The new shares will be issued using existing proxies. The new shares will be offered in combination with a proposed issue of warrants.

The purpose of the placement is to finance operating costs and to strengthen the company’s working capital requirements.


Oslo, 25 November, 2009

The Board of Directors of DiaGenic ASA

DiaGenic ASA

DiaGenic ASA is an innovative Norwegian life sciences company founded in 1998 and listed on the Oslo Stock Exchange.

DiaGenic develops patient-friendly tests for the early diagnosis of devastating diseases where early in...

View more


  CONTACT  
 
 
 
 
Social Media Pitch:
Financing DiaGenic ASA